This is your chance to get involved - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

This is your chance to get involved


Pharmaceutical Technology Europe
Volume 22, Issue 6


Fedra Pavlou
Have you ever come across a new technology, process or problem in your profession and wanted to tell others or learn more about it? Or have you read through your issue of PTE and wished that the editors would publish more articles on a particular subject? If so, I'd really like to hear from you. This month sees the launch of PTE's annual readership survey ( http://www.pharmtech.com/survey2010). I always look forward to reading the results of this survey because it helps me to better understand what it is that you want from your monthly magazine and digital products. Ultimately, it helps me to do my job better and that is to provide the information that you want to read at the right time and in the right format.

If the opportunity of having direct input into PTE's editorial direction isn't enough of an incentive for you, then let me also tell you that all survey respondents will be entered into a prize draw to win an iPod Touch. The winner will be announced on our website ( http://www.pharmtech.com) in July as well as in PTE's eNewsletter.

I urge you take the time to complete this short online form, which is available on our website ( http://www.pharmtech.com/survey2010) and I guarantee it should take no longer than 5 minutes of your time. If you don't take part, I'll assume you think we're great just the way we are :-)

As always, thank you for your continued support.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Pharmaceutical Technology Europe,
Click here